This report contains market size and forecasts of Bipolar Disorder in Global, including the following market information:
Global Bipolar Disorder Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global top five companies in 2020 (%)
The global Bipolar Disorder market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Bipolar Disorder companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Bipolar Disorder Market, By Type, 2016-2021, 2022-2027 ($ millions)
Global Bipolar Disorder Market Segment Percentages, By Type, 2020 (%)
Bipolar I Disorder
Bipolar II Disorder
Cyclothymic Disorder
China Bipolar Disorder Market, By Application, 2016-2021, 2022-2027 ($ millions)
China Bipolar Disorder Market Segment Percentages, By Application, 2020 (%)
Mood Stabilizers
Anticonvulsants
Antipsychotic drugs
Antidepressant drugs
Antianxiety drugs
Others
Global Bipolar Disorder Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)
Global Bipolar Disorder Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Total Bipolar Disorder Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)
Total Bipolar Disorder Market Competitors Revenues Share in Global, by Players 2020 (%)
Further, the report presents profiles of competitors in the market, including the following:
Glaxo SmithKline (GSK)
Pfizer Inc.
Janssen Pharmaceuticals
Eli Lilly
Allergan Plc.
Novartis AG
AbbVie Inc.
Otsuka Holdings Ltd
AstraZeneca
Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Bipolar Disorder Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Bipolar Disorder Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Bipolar Disorder Overall Market Size
2.1 Global Bipolar Disorder Market Size: 2021 VS 2027
2.2 Global Bipolar Disorder Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Bipolar Disorder Players in Global Market
3.2 Top Global Bipolar Disorder Companies Ranked by Revenue
3.3 Global Bipolar Disorder Revenue by Companies
3.4 Top 3 and Top 5 Bipolar Disorder Companies in Global Market, by Revenue in 2020
3.5 Global Companies Bipolar Disorder Product Type
3.6 Tier 1, Tier 2 and Tier 3 Bipolar Disorder Players in Global Market
3.6.1 List of Global Tier 1 Bipolar Disorder Companies
3.6.2 List of Global Tier 2 and Tier 3 Bipolar Disorder Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Bipolar Disorder Market Size Markets, 2021 & 2027
4.1.2 Bipolar I Disorder
4.1.3 Bipolar II Disorder
4.1.4 Cyclothymic Disorder
4.2 By Type - Global Bipolar Disorder Revenue & Forecasts
4.2.1 By Type - Global Bipolar Disorder Revenue, 2016-2021
4.2.2 By Type - Global Bipolar Disorder Revenue, 2022-2027
4.2.3 By Type - Global Bipolar Disorder Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Bipolar Disorder Market Size, 2021 & 2027
5.1.2 Mood Stabilizers
5.1.3 Anticonvulsants
5.1.4 Antipsychotic drugs
5.1.5 Antidepressant drugs
5.1.6 Antianxiety drugs
5.1.7 Others
5.2 By Application - Global Bipolar Disorder Revenue & Forecasts
5.2.1 By Application - Global Bipolar Disorder Revenue, 2016-2021
5.2.2 By Application - Global Bipolar Disorder Revenue, 2022-2027
5.2.3 By Application - Global Bipolar Disorder Revenue Market Share, 2016-2027
6 Sights by Region
6.1 By Region - Global Bipolar Disorder Market Size, 2021 & 2027
6.2 By Region - Global Bipolar Disorder Revenue & Forecasts
6.2.1 By Region - Global Bipolar Disorder Revenue, 2016-2021
6.2.2 By Region - Global Bipolar Disorder Revenue, 2022-2027
6.2.3 By Region - Global Bipolar Disorder Revenue Market Share, 2016-2027
6.3 North America
6.3.1 By Country - North America Bipolar Disorder Revenue, 2016-2027
6.3.2 US Bipolar Disorder Market Size, 2016-2027
6.3.3 Canada Bipolar Disorder Market Size, 2016-2027
6.3.4 Mexico Bipolar Disorder Market Size, 2016-2027
6.4 Europe
6.4.1 By Country - Europe Bipolar Disorder Revenue, 2016-2027
6.4.2 Germany Bipolar Disorder Market Size, 2016-2027
6.4.3 France Bipolar Disorder Market Size, 2016-2027
6.4.4 U.K. Bipolar Disorder Market Size, 2016-2027
6.4.5 Italy Bipolar Disorder Market Size, 2016-2027
6.4.6 Russia Bipolar Disorder Market Size, 2016-2027
6.4.7 Nordic Countries Bipolar Disorder Market Size, 2016-2027
6.4.8 Benelux Bipolar Disorder Market Size, 2016-2027
6.5 Asia
6.5.1 By Region - Asia Bipolar Disorder Revenue, 2016-2027
6.5.2 China Bipolar Disorder Market Size, 2016-2027
6.5.3 Japan Bipolar Disorder Market Size, 2016-2027
6.5.4 South Korea Bipolar Disorder Market Size, 2016-2027
6.5.5 Southeast Asia Bipolar Disorder Market Size, 2016-2027
6.5.6 India Bipolar Disorder Market Size, 2016-2027
6.6 South America
6.6.1 By Country - South America Bipolar Disorder Revenue, 2016-2027
6.6.2 Brazil Bipolar Disorder Market Size, 2016-2027
6.6.3 Argentina Bipolar Disorder Market Size, 2016-2027
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Bipolar Disorder Revenue, 2016-2027
6.7.2 Turkey Bipolar Disorder Market Size, 2016-2027
6.7.3 Israel Bipolar Disorder Market Size, 2016-2027
6.7.4 Saudi Arabia Bipolar Disorder Market Size, 2016-2027
6.7.5 UAE Bipolar Disorder Market Size, 2016-2027
7 Players Profiles
7.1 Glaxo SmithKline (GSK)
7.1.1 Glaxo SmithKline (GSK) Corporate Summary
7.1.2 Glaxo SmithKline (GSK) Business Overview
7.1.3 Glaxo SmithKline (GSK) Bipolar Disorder Major Product Offerings
7.1.4 Glaxo SmithKline (GSK) Bipolar Disorder Revenue in Global (2016-2021)
7.1.5 Glaxo SmithKline (GSK) Key News
7.2 Pfizer Inc.
7.2.1 Pfizer Inc. Corporate Summary
7.2.2 Pfizer Inc. Business Overview
7.2.3 Pfizer Inc. Bipolar Disorder Major Product Offerings
7.2.4 Pfizer Inc. Bipolar Disorder Revenue in Global (2016-2021)
7.2.5 Pfizer Inc. Key News
7.3 Janssen Pharmaceuticals
7.3.1 Janssen Pharmaceuticals Corporate Summary
7.3.2 Janssen Pharmaceuticals Business Overview
7.3.3 Janssen Pharmaceuticals Bipolar Disorder Major Product Offerings
7.3.4 Janssen Pharmaceuticals Bipolar Disorder Revenue in Global (2016-2021)
7.3.5 Janssen Pharmaceuticals Key News
7.4 Eli Lilly
7.4.1 Eli Lilly Corporate Summary
7.4.2 Eli Lilly Business Overview
7.4.3 Eli Lilly Bipolar Disorder Major Product Offerings
7.4.4 Eli Lilly Bipolar Disorder Revenue in Global (2016-2021)
7.4.5 Eli Lilly Key News
7.5 Allergan Plc.
7.5.1 Allergan Plc. Corporate Summary
7.5.2 Allergan Plc. Business Overview
7.5.3 Allergan Plc. Bipolar Disorder Major Product Offerings
7.5.4 Allergan Plc. Bipolar Disorder Revenue in Global (2016-2021)
7.5.5 Allergan Plc. Key News
7.6 Novartis AG
7.6.1 Novartis AG Corporate Summary
7.6.2 Novartis AG Business Overview
7.6.3 Novartis AG Bipolar Disorder Major Product Offerings
7.6.4 Novartis AG Bipolar Disorder Revenue in Global (2016-2021)
7.6.5 Novartis AG Key News
7.7 AbbVie Inc.
7.7.1 AbbVie Inc. Corporate Summary
7.7.2 AbbVie Inc. Business Overview
7.7.3 AbbVie Inc. Bipolar Disorder Major Product Offerings
7.4.4 AbbVie Inc. Bipolar Disorder Revenue in Global (2016-2021)
7.7.5 AbbVie Inc. Key News
7.8 Otsuka Holdings Ltd
7.8.1 Otsuka Holdings Ltd Corporate Summary
7.8.2 Otsuka Holdings Ltd Business Overview
7.8.3 Otsuka Holdings Ltd Bipolar Disorder Major Product Offerings
7.8.4 Otsuka Holdings Ltd Bipolar Disorder Revenue in Global (2016-2021)
7.8.5 Otsuka Holdings Ltd Key News
7.9 AstraZeneca
7.9.1 AstraZeneca Corporate Summary
7.9.2 AstraZeneca Business Overview
7.9.3 AstraZeneca Bipolar Disorder Major Product Offerings
7.9.4 AstraZeneca Bipolar Disorder Revenue in Global (2016-2021)
7.9.5 AstraZeneca Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Bipolar Disorder Market Opportunities & Trends in Global Market
Table 2. Bipolar Disorder Market Drivers in Global Market
Table 3. Bipolar Disorder Market Restraints in Global Market
Table 4. Key Players of Bipolar Disorder in Global Market
Table 5. Top Bipolar Disorder Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Bipolar Disorder Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Bipolar Disorder Revenue Share by Companies, 2016-2021
Table 8. Global Companies Bipolar Disorder Product Type
Table 9. List of Global Tier 1 Bipolar Disorder Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Bipolar Disorder Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type
Glaxo SmithKline (GSK)
Pfizer Inc.
Janssen Pharmaceuticals
Eli Lilly
Allergan Plc.
Novartis AG
AbbVie Inc.
Otsuka Holdings Ltd
AstraZeneca